A detailed history of Convergence Investment Partners, LLC transactions in Viatris Inc stock. As of the latest transaction made, Convergence Investment Partners, LLC holds 52,383 shares of VTRS stock, worth $540,592. This represents 0.24% of its overall portfolio holdings.

Number of Shares
52,383
Previous 22,439 133.45%
Holding current value
$540,592
Previous $243,000 157.2%
% of portfolio
0.24%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$11.27 - $13.53 $337,468 - $405,142
29,944 Added 133.45%
52,383 $625,000
Q4 2023

Feb 05, 2024

BUY
$8.77 - $10.85 $196,790 - $243,463
22,439 New
22,439 $243,000
Q1 2023

May 09, 2023

BUY
$9.2 - $12.26 $138,082 - $184,010
15,009 New
15,009 $144,000
Q2 2022

Aug 05, 2022

BUY
$9.95 - $12.27 $110,643 - $136,442
11,120 New
11,120 $116,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.5B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Convergence Investment Partners, LLC Portfolio

Follow Convergence Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Investment Partners, LLC with notifications on news.